Ciladopa hydrochloride

2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-amine is a pharmaceutically active compound which is a nootropic agent that acts as cholinesterase inhibitor and is used in research of Alzheimer disease.

Application 2-Methyl-1,3-cyclopentanedione hs been used to explore deoxycholic acid (DCA) induced changes in cell signaling. DCA is a secondary bile acid implicated in numerous pathological conditions .

3-Cyano-7-hydroxy-4-methylcoumarin has been isolated from Curcuma longa isopropanol extract. Application 3-Cyano-7-hydroxy-4-methylcoumarin (CHMC) may be used as reagent for the stereo-specific preparation of R P - and S P -O -alkyl

4-METHOXYPHENYL CINNAMATE

4-Quinolinecarboxaldehyde(cinchoninaldehyde) was used in the synthesis of lepidylamines.

4-Quinolinecarboxaldehyde(cinchoninaldehyde) was used in the synthesis of lepidylamines.

4-Quinolinecarboxaldehyde(cinchoninaldehyde) was used in the synthesis of lepidylamines.

4-Quinolinecarboxaldehyde(cinchoninaldehyde) was used in the synthesis of lepidylamines.

6-Hydroxydopa is the precursor of the catecholaminergic neurotoxin, 6-hydroxydopamine: converted to 6-hydroxydopamine by L-aromatic amino acid decarboxylase. Used in the study of Parkinson's disease.

6-Hydroxydopa is the precursor of the catecholaminergic neurotoxin, 6-hydroxydopamine: converted to 6-hydroxydopamine by L-aromatic amino acid decarboxylase. Used in the study of Parkinson's disease.

6-Hydroxydopa is the precursor of the catecholaminergic neurotoxin, 6-hydroxydopamine: converted to 6-hydroxydopamine by L-aromatic amino acid decarboxylase. Used in the study of Parkinson's disease.

6-Hydroxydopa is the precursor of the catecholaminergic neurotoxin, 6-hydroxydopamine: converted to 6-hydroxydopamine by L-aromatic amino acid decarboxylase. Used in the study of Parkinson's disease.